ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) Stock Price, Forecast & Analysis
USA - NASDAQ:ZYBT - KYG989MS1016 - Common Stock
ZYBT Key Statistics, Chart & Performance
The current stock price of ZYBT is 2.13 USD. In the past month the price decreased by -15.14%.
ZYBT Latest News, Press Relases and Analysis
ZYBT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 47.25 | 983.46B | ||
| JNJ | JOHNSON & JOHNSON | 19.37 | 484.15B | ||
| MRK | MERCK & CO. INC. | 10.89 | 239.69B | ||
| PFE | PFIZER INC | 7.93 | 144.21B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.04 | 93.98B | ||
| ZTS | ZOETIS INC | 18.49 | 51.95B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.42 | 22.59B | ||
| VTRS | VIATRIS INC | 4.54 | 12.34B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.66 | 10.81B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.59 | 7.94B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.33B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 4.31B |
Related stock screener links
About ZYBT
Company Profile
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.
Company Info
ZHENGYE BIOTECHNOLOGY HOLDIN
No.1 Lianmeng Street, Jilin Economic &, Technical Development Zone
Jilin JILIN CN
Employees: 277
ZHENGYE BIOTECHNOLOGY HOLDIN / ZYBT FAQ
What does ZHENGYE BIOTECHNOLOGY HOLDIN do?
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.
Can you provide the latest stock price for ZHENGYE BIOTECHNOLOGY HOLDIN?
The current stock price of ZYBT is 2.13 USD. The price decreased by -2.52% in the last trading session.
Does ZYBT stock pay dividends?
ZYBT does not pay a dividend.
What is the ChartMill technical and fundamental rating of ZYBT stock?
ZYBT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the employee count for ZYBT stock?
ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) currently has 277 employees.
What is the market capitalization of ZYBT stock?
ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) has a market capitalization of 100.94M USD. This makes ZYBT a Micro Cap stock.
ZYBT Technical Analysis
ZYBT Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ZYBT. ZYBT has an average financial health and profitability rating.
ZYBT Financial Highlights
Over the last trailing twelve months ZYBT reported a non-GAAP Earnings per Share(EPS) of 0.12. The EPS increased by 21.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.95% | ||
| ROA | 7.96% | ||
| ROE | 13.83% | ||
| Debt/Equity | 0.02 |